Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Committee Votes topic

No spam. Unsubscribe anytime.

Public Health Committee approves two bills; prescription monitoring changes advance

Public Health Committee · February 17, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The committee unanimously approved two items, including a change to the state prescription monitoring reporting window in SB 262, and recorded a separate unanimous vote on bill 293. A larger compounding/med‑spa bill (SB 282) was discussed at length and held for amendments.

The Public Health Committee voted unanimously on two measures during its morning session, including changes to the state prescription drug monitoring program and a separate bill identified as 293. The committee also took extensive testimony on Senate Bill 282, which concerns compounding pharmacy standards and medical spa regulation, and agreed to work on further amendments before returning to the bill.

The first action the committee considered was an amendment taken by consent; the clerk’s roll call produced a 10–0 recorded passage after several members were excused. The hearing then considered Senate Bill 262, introduced by Senator Kreider, which removes a 72‑hour reporting exemption in the INSPECT prescription drug monitoring program, clarifies what data counts as prescription drug monitoring program data, and allows certain data sharing with the state department of health and FSSA to support overdose‑reduction programming. Senator Kreider told the committee the bill aligns reporting and definitions to give prescribers more visibility into patients’ prescription histories.

Witnesses including Dr. Ryan Singerman of the Indiana State Medical Association supported SB 262 as a clinical tool to reduce overprescribing, while urging clear confidentiality protections for data once it leaves the INSPECT system. Representative Barrett moved the amended SB 262 to a second vote; the clerk conducted roll call and the chair announced the bill passed 11–0. Representative Porter recorded his ‘Aye’ during that roll call. Later the committee recorded a vote on bill 293 with Representative Porter voting in favor; the chair summarized that both bills passed unanimously.

SB 282 — the broader compounding and medical‑spa measure — received the bulk of the day’s testimony and was not put to a vote. Chair Barrett said she will work on a revised amendment and bring the bill back later in the week for further consideration.

Votes at a glance: - Amendment (taken by consent): passed 10–0 (roll call). - Senate Bill 262 (INSPECT reporting; second vote): passed 11–0 (roll call). - Bill 293: recorded as passed; Representative Porter recorded an affirmative vote during proceedings.

The committee adjourned after scheduling further work on SB 282.